APA

Reimand J., Groot C., Teunissen C. E., Windhorst A. D., Boellaard R., Barkhof F., Nazarenko S., van der Flier W. M., van Berckel B. N. M., Scheltens P., Ossenkoppele R. & Bouwman F. (20201118). Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?. : Journal of Alzheimer's disease : JAD.

Chicago

Reimand Juhan, Groot Colin, Teunissen Charlotte E, Windhorst Albert D, Boellaard Ronald, Barkhof Frederik, Nazarenko Sergei, van der Flier Wiesje M, van Berckel Bart N M, Scheltens Philip, Ossenkoppele Rik and Bouwman Femke. 20201118. Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?. : Journal of Alzheimer's disease : JAD.

Harvard

Reimand J., Groot C., Teunissen C. E., Windhorst A. D., Boellaard R., Barkhof F., Nazarenko S., van der Flier W. M., van Berckel B. N. M., Scheltens P., Ossenkoppele R. and Bouwman F. (20201118). Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?. : Journal of Alzheimer's disease : JAD.

MLA

Reimand Juhan, Groot Colin, Teunissen Charlotte E, Windhorst Albert D, Boellaard Ronald, Barkhof Frederik, Nazarenko Sergei, van der Flier Wiesje M, van Berckel Bart N M, Scheltens Philip, Ossenkoppele Rik and Bouwman Femke. Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?. : Journal of Alzheimer's disease : JAD. 20201118.